Berstein, L.M.; Tsyrlina, E.V.; Poroshina, T.E.; Levina, V.V.; Vasilyev, D.A.; Kovalenko, I.G.; Semiglazov, V.F.
(Experimental Oncology, 2006)
Aim: About 30–40% of breast cancers lack steroid receptors (ER and/or PR) at diagnosis that worsen prognosis and limit the usage of hormone therapy. The aim of this paper has been to study the role of DNA-damaging factors ...